Clinical trial · Observational
Integrative Omics Analysis for Colorectal Cancer and Metastasis
A Prospective Study of Integrative Omics Analysis for Colorectal Cancer and Metastasis
NCT05482529CI-TRIAL-00059992unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The pathogenesis of Colorectal cancer (CRC) metastasis remains unclear.We collect clinical data from our center and use Integrative omics to analyze and predict candidate biomarkers of colorectal cancer and distant metastasis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Integrative omics | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- colorectal cancer with metastasis
- description
- colorectal cancer patients with at least one distant metastasis(liver, lung)
- interventionNames
- Other: Integrative omics
Primary outcomes (2)
- measure
- overall survival rate
- timeFrame
- 3 years after surgery
- description
- the oncological efficacy by 3-year follow-up according to the NCCN guideline. Participants should report every follow-up examinations which prove tumor recurrence and/or metastasis or not.
- measure
- disease free survival rate
- timeFrame
- 3 years after surgery
- description
- the oncological efficacy by 3-year follow-up according to the NCCN guideline. Participants should report every follow-up examinations which prove tumor recurrence and/or metastasis or not.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * colorectal adenocarcinoma by biopsy。 * at least 1 metastasis lesion comfirmed by at least 1 kind of imaging examination (CT, MRI and PET-CT ) Exclusion Criteria: * recent diagnosis with other malignancies * can not tolerate the surgery * history of serious mental illness * pregnancy or lactating women * the researchers believe the patients should not enrolled in
References
Publications (0)
Data not yet available
No reference posted for this study.